2026 Seattle Cellular Therapy Summit

Accreditation: 12.75 Nursing Contact Hours | 12.75 ABIM MOC II | 12.75 AMA PRA Category 1 Credit™ | 12.75 ACPE Pharmacy

Venue: Bell Harbor International Conference Center , 2211 Alaskan Way, Seattle, WA, 98121, United States

Start Date: Aug 14End Date: Aug 15, 2026

Claim Now

Overview

Trusted by Thousands of Attendees
Across Our Events

81+

Email if you have questions

Our Speakers

Planning Committee

Binay Shah, MD, MHA

Conference Director

Binayatara

Krish Patel, MD

Conference Co-Chair

Mazyar Shadman, MD, MPH

Conference Co-Chair

Fred Hutch Cancer Center/University of Washington

Faculty

Lawrence Fong, MD

Session Chair

Fred Hutch Cancer Center

Natalie Wuliji, DO

Session Chair

Fred Hutch Cancer Center

Nirav N. Shah, MD, MS

Session Chair

Medical College of Wisconsin

Jordan Gauthier, MD, M.Sc

Session Chair

Clinical Research Division, Fred Hutchinson Cancer Center

Rahul Banerjee, MD

Session Chair

Clinical Research Division, Fred Hutchinson Cancer Center

Folashade Otegbeye, MPH, MBChB

Session Chair

Clinical Research Division, Fred Hutchinson Cancer Center

Filippo Milano, MD, PhD

Session Chair

Clinical Research Division, Fred Hutchinson Cancer Center

Alexey Danilov, MD, PhD

Session Chair

City of Hope

Alan Skarbnik, MD

Session Chair

Director, Lymphoma and CLL Program and Immune Effector Cell Therapeutics Program, Novant Health Cancer Institute

Mengyang Di, MD, PhD

Topic Presenter

University of Washington/Fred Hutch Cancer Center

Andrew Cowan, MD

Topic Presenter

BC Cancer Agency

Soheil Meshinchi, MD, PhD

Topic Presenter

Matthew Alexander Lunning, DO

Topic Presenter

University of Nebraska Medical Center

Brian Hill, MD, PhD

Topic Presenter

Cleveland Clinic Foundation

Nilanjan Ghosh, MD, PhD

Topic Presenter

Atrium Health Levine Cancer Institute, Wake Forest University School of Medicine

Paolo Strati, MD

Topic Presenter

The University of Texas MD Anderson Cancer Center

Sibel Blau, MD

Topic Presenter

Northwest Medical Specialties, PLLC

Murali Janakiram, MD

Topic Presenter

CITY OF HOPE

Hitomi Hosoya, MD PhD

Topic Presenter

Yucai Wang, MD, PhD

Topic Presenter

Mayo clinic

Andrew Jay Portuguese, MD

Topic Presenter

Clinical Research Division, Fred Hutchinson Cancer Center

Hira Shaikh, MD

Topic Presenter

University of Iowa

Ryan Cassaday, MD

Topic Presenter

University of Washington & Fred Hutch Cancer Center

Sid Devarakonda, MD

Topic Presenter

Lara E. Davis, MD

Topic Presenter

Fred Hutchinson Cancer Center

Hany Elmariah, MD, MS

Topic Presenter

Stanford University School of Medicine

Hans-Peter Kiem, MD, PhD

Topic Presenter

Fred Hutchinson Cancer Center (FHCC)

Max Julve, MD

Topic Presenter

Jennifer Huang, MD, PhD

Topic Presenter

Fred Hutch Cancer Center/University of Washington

Saurabh Dahiya, MD

Topic Presenter

Stanford University

Sonali Smith, MD

Topic Presenter

University of Chicago

Agenda

Day 1: Friday, August 14th, 2026

All timings are in Pacific Time (PDT, GMT-07:00) time.

08:00 AM - 09:30 AMRegistration, Breakfast, & Exhibits (Sound Room)

09:30 AM - 09:45 AMWelcome & Opening Remarks (Bay Auditorium)

09:45 AM - 11:15 AMSession 1 : Solid Tumors I (Bay Auditorium)

Session Chair: Lawrence Fong, MD

09:45 AM - 10:00 AM

Immuno-oncology for GU Malignancies – Lawrence Fong, MD

10:00 AM - 10:15 AM

Lung Cancer: Tarlatamab – Sid Devarakonda, MD

10:15 AM - 10:30 AM

Malignant Melanoma: Lifileucel and Beyond – Max Julve, MD

10:30 AM - 10:45 AM

Immunotherapy for Sarcoma – Lara E. Davis, MD

10:45 AM - 11:15 AM

Panel Discussion

Moderators:

Lawrence Fong, MD

Panelists:

Sid Devarakonda, MD; Max Julve, MD; Lara E. Davis, MD

11:15 AM - 12:15 PMSession 2 : Solid Tumors II (Bay Auditorium)

Session Chair: Folashade Otegbeye, MPH, MBChB

11:15 AM - 11:30 AM

Novel FOLR1 CAR-T Therapy – Soheil Meshinchi, MD, PhD

11:30 AM - 11:45 AM

FACT Standards for Immune Effector Cells in the Community Setting – Folashade Otegbeye, MPH, MBChB

11:45 AM - 12:15 PM

Panel Discussion

Moderators:

Folashade Otegbeye, MPH, MBChB

Panelists:

Soheil Meshinchi, MD, PhD

12:15 PM - 01:15 PMLunch & Exhibits (Sound)

01:15 PM - 02:30 PMSession 3 : CAR-T Cells — The Next Breakthroughs (Bay Auditorium)

Session Chair: Natalie Wuliji, DO

01:15 PM - 01:30 PM

Multispecific CAR-T — Will They Change Our Standard of Care? – Saurabh Dahiya, MD

01:30 PM - 01:45 PM

In-Vivo CAR-T Platforms – Hans-Peter Kiem, MD, PhD

01:45 PM - 02:00 PM

CAR-T Therapy for Autoimmune Disorders – Natalie Wuliji, DO

02:00 PM - 02:30 PM

Panel Discussion

Moderators:

Natalie Wuliji, DO

Panelists:

Saurabh Dahiya, MD; Hans-Peter Kiem, MD, PhD

02:30 PM - 02:45 PMBreak & Exhibits (Sound)

02:45 PM - 03:45 PMSession 4 : Leukemia and Transplant (Bay Auditorium)

Session Chair: Filippo Milano, MD, PhD

02:45 PM - 03:00 PM

Immunotherapy for Myeloid Malignancies — Challenges and Promises – Hany Elmariah, MD, MS

03:00 PM - 03:15 PM

Cellular Therapy in Allogeneic Transplant (Orca-T, Omidubicel and Beyond) – Filippo Milano, MD, PhD

03:15 PM - 03:30 PM

ALL — Focus on Immunotherapeutic Approaches, Approved and Investigational Options – Ryan Cassaday, MD

03:30 PM - 03:45 PM

Panel Discussion

Moderators:

Filippo Milano, MD, PhD

Panelists:

Hany Elmariah, MD, MS; Ryan Cassaday, MD

03:45 PM - 04:45 PMSession 5 : Chronic Lymphocytic Leukemia (Bay Auditorium)

Session Chair: Alexey Danilov, MD, PhD

03:45 PM - 04:00 PM

Immunotherapy (CAR-T and Bispecific Antibodies) for CLL – Jennifer Huang, MD, PhD

04:00 PM - 04:15 PM

How Will CLL Be Treated in 2030? – Alexey Danilov, MD, PhD

04:15 PM - 04:45 PM

Panel Discussion

Moderators:

Alexey Danilov, MD, PhD

Panelists:

Jennifer Huang, MD, PhD

Day 2: Saturday, August 15th, 2026

07:00 AM - 08:00 AMRegistration, Breakfast, & Exhibits (Sound Room)

08:00 AM - 09:30 AMSession 6 : Topics in T-Cell Engaging Therapies (Bay Auditorium)

Session Chair: Mazyar Shadman, MD, MPH

08:00 AM - 08:15 AM

Barriers to CAR-T Use — Challenges and Opportunities – Mazyar Shadman, MD, MPH

08:15 AM - 08:30 AM

Bispecific Antibodies in Community Setting — General Principles – Sibel Blau, MD

08:30 AM - 08:45 AM

Next-Generation T-Cell Engagers – Krish Patel, MD

08:45 AM - 09:00 AM

State of Cellular Immunotherapy in 2030 – Matthew Alexander Lunning, DO

09:00 AM - 09:30 AM

Panel Discussion

Moderators:

Mazyar Shadman, MD, MPH

Panelists:

Sibel Blau, MD; Krish Patel, MD; Matthew Alexander Lunning, DO

09:30 AM - 10:30 AMSession 7 : Aggressive B-Cell Lymphoma (Bay Auditorium)

Session Chair: Krish Patel, MD

09:30 AM - 09:45 AM

Current Role of Immunotherapy in Treatment of DLBCL – Nilanjan Ghosh, MD, PhD

09:45 AM - 10:00 AM

How Will DLBCL Be Treated in 2030? – Sonali Smith, MD

10:00 AM - 10:30 AM

Panel Discussion

Moderators:

Krish Patel, MD

Panelists:

Nilanjan Ghosh, MD, PhD; Sonali Smith, MD

Acknowledgement of Commercial Support

This activity is supported with an Independent Medical Education grant from Amgen.

About 2026 Seattle Cellular Therapy Summit

Overview

Faculty and committee

Our Speakers

Planning Committee

Faculty

Conference program and agenda

Agenda

Venue and map

Accreditations and continuing education

Acknowledgement of Commercial Support

Registration and pricing

Exhibitors and sponsorship